Literature DB >> 2682505

The shiga-like toxin-producing Escherichia coli and hemolytic uremic syndrome.

T G Cleary1, E L Lopez.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2682505     DOI： 10.1097/00006454-198910000-00012

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN： 0891-3668            Impact factor:   2.129


× No keyword cloud information.
  6 in total

1.  Indirect hemagglutination assay for diagnosis of Escherichia coli O157 infection in patients with hemolytic-uremic syndrome.

Authors:  M Bitzan; H Karch
Journal:  J Clin Microbiol       Date:  1992-05       Impact factor: 5.948

2.  Haemolytic anaemia after childhood Escherichia coli O 157 .H7 infection: are females at increased risk?

Authors:  P C Rowe; W Walop; H Lior; A M Mackenzie
Journal:  Epidemiol Infect       Date:  1991-06       Impact factor: 2.451

3.  Immune response to verotoxin 1 and 2 in children with Escherichia coli O157:H7 hemorrhagic colitis and classic hemolytic uremic syndrome.

Authors:  F Proulx; J P Turgeon; G Delage; H Lior; L Lafleur; L Chicoine
Journal:  Can J Infect Dis       Date:  1995-05

4.  Pneumococcal Induced T-activation with Resultant Thrombotic Microangiopathy.

Authors:  J W Oliver; R S Akins; M K Bibens; D M Dunn
Journal:  Clin Med Insights Pathol       Date:  2010-05-19

5.  Products of enteropathogenic Escherichia coli inhibit lymphocyte activation and lymphokine production.

Authors:  J M Klapproth; M S Donnenberg; J M Abraham; H L Mobley; S P James
Journal:  Infect Immun       Date:  1995-06       Impact factor: 3.441

6.  Pneumococcus-induced T-antigen activation in hemolytic uremic syndrome and anemia.

Authors:  Joel B Cochran; Valerie M Panzarino; Lanne Y Maes; Frederick W Tecklenburg
Journal:  Pediatr Nephrol       Date:  2004-01-09       Impact factor: 3.714
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.